Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MR-LINAC Radiotherapy and Surgery after Induction Chemotherapy in LAPC
NCT07871461Phase 2Not yet recruiting
- Sponsor
- Allegheny Singer Research Institute
- Start
- Oct 2026
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in pancreatic cancer (PC), sponsored by Allegheny Singer Research Institute. Primary endpoint: R0 Resection Rate. Planned start Oct 2026; status: not yet recruiting.
02
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT07871461.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07871461.